Islet Transplantation in Type 1 Diabetes with LEA29Y (Belatacept) Maintenance Therapy
收藏DataCite Commons2023-01-13 更新2024-07-13 收录
下载链接：
https://repository.niddk.nih.gov/studies/cit-04
下载链接
链接失效反馈官方服务：
资源简介：
The CIT consortium conducted a total of 9 studies across North America (CIT02 through CIT08) and the Nordic region (CIT01). CIT08 was a long-term follow-up study for interested participants at the North American sites. The target population was individuals with type 1 diabetes, normal kidney function, and intractable hypoglycemia. All studies treated participants with up to 3 separate infusions of islets. The focus of CIT04 was to evaluate the effectiveness of an IS regimen that included belatacept. For immunosuppression, CIT04 subjects received belatacept, basiliximab, and mycophenolate mofetil in an open-label fashion.
提供机构：
NIDDK Central Repository
创建时间：
2023-01-13
